Hepatitis Treatment News
A Smart + Strong Site
Subscribe to:
Hep Magazine In Bulk
Hep Newsletter
Join Us:

Back to home » Hepatitis Treatment News


December 19, 2014
FDA Approves AbbVie's Hepatitis C Regimen Viekira Pak
The U.S. Food and Drug Administration has approved AbbVie's Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets) to treat hepatitis C virus (HCV) genotype 1.
December 17, 2014
Fibrosis Progresses Quickly During First 5 Years of Hep C Infection
Liver fibrosis tends to progress rapidly after individuals contract hepatitis C.
December 15, 2014
Hepatitis C Linked to Accelerated Immune Cell Differentiation
Hepatitis C is linked to accelerated differentiation of CD4 and CD8 cells—major building blocks of the immune system—into specific phenotypes.
December 10, 2014
Europe Recommends Approval of AbbVie’s ‘3D’ Hep C Regimen
A regulatory committee has recommended that the European Medicines Agency approve AbbVie’s “3D” regimen to treat genotypes 1 and 4 of hepatitis C, with or without ribavirin.
December 05, 2014
Viread Effectively Combats Hepatitis B for at Least 8 Years
Viread (tenofovir) is highly effective at suppressing hepatitis B, even after an eight-year period.
December 03, 2014
Hep C Hospitalizations and Related Costs Are On the Rise
Hospitalizations because of hepatitis C have steadily increased in recent years, posing a significant financial burden to the U.S. health care system.
December 01, 2014
FDA Requests More Data on BMS’s Hep C Drug Daclatasvir
The FDA has requested additional data from BMS about the hepatitis C drug daclatasvir’s use in combination with other direct-acting antivirals.
Archives
   

December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
January 2008


QUICK LINKS

Current Issue
Forums
Poll
Blogs
Hep Stories
Calendar
Services Directory
Conference News
Top Stories
Treatment News
Hep Exclusives
All About Hepatitis
• Hepatitis A
Transmission
Prevention
Treatment
• Hepatitis B
Transmission
Prevention
Treatment
• Hepatitis C
Transmission
Prevention
Treatment
HCV/HIV Coinfection
Help Paying For Meds
Clinical Trials
TALK TO US
Tell us what you think
Poll
Have you gotten headaches while on hep C treatment?
Yes
No


Survey
Hepatitis C Reader Survey
HEP ON TWITTER
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.